Interests: Breast Cancer, Cervix Cancer, Gynecologic Malignancies, Brachytherapy, Stereotactic Radio Surgery (SRS), Stereotactic Body Radiotherapy (SBRT)
Dr. Fisher is a board certified
radiation oncologist at University of Colorado with a focus on individualized,
compassionate patient care. She completed her residency in radiation
oncology at MD Anderson Cancer Center in Houston, TX and earned her MPH from
University of North Carolina, Chapel Hill where her thesis focused on the use
of brachytherapy in radiation treatment. She has also worked in an
immunology laboratory focusing on clinical trials with immunomodulation via
novel vaccine therapies in a Phase I and Phase II. Her clinical interests include using
radiation in higher doses for better tumor control and outcome, using both
brachytherapy and stereotactic techniques (SBRT, SRS).
She has published more than 100
publications including scientific articles and book chapters with a focus in
women’s cancers and regularly presents her research at national and
international scientific meetings. She is the Principle Investigator on
multiple trials in breast and gynecologic cancer focusing on giving the best
care to each patient. She has a strong
interest in health outcomes, comparative effectiveness, and using all available
data to select the best treatment individually for each patient.
Dr. Fisher is honored to serve
on the NCCN (National Comprehensive Cancer Network) guidelines committee for
Cervix, Uterine, and Vulvar cancers, helping design national guidelines for
practitioners to use in these challenging diagnoses. She is an IDEA Mentor for ASCO, helping train
oncologists from low to middle income countries in delivering efficient, data
driven care. She serves as a Chartrounds
expert in gynecologic cancer and has supported Chartrounds India to bring
advanced cancer care to this country, with a special focus on cervical cancer
treatment and outcomes.
She currently serves as Director of the Brachytherapy Program and Residency
Program Director for the Department of Radiation Oncology. She is Co-Director of the Women's Cancer
Developmental Therapeutics Program focused on advancing cancer outcomes and
patient access to novel clinical trials.